Scientists said the British-led study provides more hope than ever before that the condition could be tackled through new ...

The FDA has expanded the approval of Lumryz (sodium oxybate) extended-release oral suspension to include treatment of pediatric narcolepsy.

Copay Assistance From The Assistance Fund Now Available for Eligible People Living With Narcolepsy. ORLANDO, FLORIDA / ACCESSWIRE / January 9, 2025 / The Assistance Fund, an indep ...

About LUMRYZ™ (sodium oxybate) for extended-release oral suspension LUMRYZ, is an extended-release sodium oxybate medication approved by the FDA on May 1, 2023, as the first and only once-at-bedtime ...

Neuraxpharm Group (Neuraxpharm), a leading European specialty pharmaceutical company focused on the treatment of central nervous system (CNS) disorders, announces today that it has acquired at the end ...

Neuraxpharm Group (Neuraxpharm), a leading European specialty pharmaceutical company focused on the treatment of central nervous system (CNS) disorders, announces today that it has acquired at the end ...

These two leading narcolepsy treatments will be added to our broad ... Caveney Architectural Collaborative to Build the Future of Adult Services in Massachusetts Melmark, a national leader in ...

Central nervous system (CNS) specialist Neuraxpharm Group has acquired Provigil (modafinil) and Nuvigil (armodafinil), both ...